Valerio Therapeutics Board Meeting Decisions

Valerio Therapeutics has outlined resolutions for approval at its Ordinary and Extraordinary Shareholders' General Meeting scheduled for April 9, 2025. Key items for the Ordinary Meeting include the dismissal of Shefali Agarwal from the Board and the ratification of the appointments of Jacques Mallet and Antoine Barouky as directors.

For the Extraordinary Meeting, proposed resolutions focus on a significant financial adjustment: splitting the company's share value from 0.14 euros to 0.01 euros per share. This aims to boost share liquidity without impacting overall capital. In addition, amendments to Article 14 of the articles of association are proposed to align with recent legislative changes from the Attractiveness law.